Meridian Bioscience, Inc.
Meridian Bioscience, Inc. (VIVO) Stock Overview
Explore Meridian Bioscience, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.5B
P/E Ratio
35.21
EPS (TTM)
$1.61
ROE
0.12%
VIVO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Meridian Bioscience, Inc. (VIVO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $60.77.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 35.21 and a market capitalization of 1.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.